This strategy document underpins the New Zealand Health Strategy 2016, which sets the direction New Zealand's health and disability services need to take into the future.

This report analysed 25 Australian clinical trials initiated by clinicians and found that if the results of the trials were implemented in just two-thirds of the relevant groups of patients for one year, $1.4 billion would be saved through improvements in patient health outcomes, and a further $580 million in reductions in health costs.

Australia is one of the world’s leading locations for the development and manufacture of medical technologies, biotechnologies and pharmaceuticals. This report demonstrates that the sector’s economic impact is significant and positive.

There is a lot of economic opportunity for Victorian companies to develop and manufacture new drugs, devices and digital health solutions that will shape the future of healthcare.

Australia needs to embrace digital health technologies and focus on data integration and standardisation.